Expert Review of Gastroenterology and Hepatology 
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.An update on improving long-term outcomes for patients with chronic pancreatitis post-surgery
Expert Rev Gastroenterol Hepatol. 2024 Feb 20. doi: 10.1080/17474124.2024.2321947. Online ahead of print.ABSTRACTINTRODUCTION: Chronic pancreatitis is a common disease that severely impairs patients' quality of life, mainly due to abdominal pain. Medical therapy alone is rarely effective to treat pain and interventional procedures are often needed. Endoscopic therapy (stricture dilatation and ductal stone removal) is usually effective in reducing pain in the short term but its effect frequently decreases with time and multiple procedures are often required.AREAS COVERED: Surgical treatment of chronic pancreatitis is based ...
Source: Expert Review of Gastroenterology and Hepatology - February 20, 2024 Category: Gastroenterology Authors: Alberto Zorzi Pietro Campagnola Antonio Amodio Federico Caldart Nicolo De Pretis Luca Frulloni Source Type: research
Development and validation of modified Liaoning score for predicting the prognosis of liver cirrhosis: a retrospective, international multicenter, observational study
CONCLUSIONS: Modified Liaoning score can be considered for predicting the long-term outcome of cirrhotic patients.PMID:38362663 | DOI:10.1080/17474124.2024.2320238 (Source: Expert Review of Gastroenterology and Hepatology)
Source: Expert Review of Gastroenterology and Hepatology - February 16, 2024 Category: Gastroenterology Authors: Xiaoting Song Fernando Gomes Romeiro Jing Wang Yue Yin Cyriac Abby Philips Xinyi Yang Xiaofeng Liu Wenming Wu Marcos Vin ícius Tiveli Bernardinelli Roger Santos de Souza Arif Hussain Theruvath Su Lin Xingshun Qi Source Type: research
Impact of the COVID-19 pandemic on hospitalizations with hepatocellular carcinoma in the United States
CONCLUSION: Hospitalization rates for viral hepatitis-related HCC remained stable, while those for HCC due to ALD and NAFLD increased during the COVID-19 pandemic.PMID:38353612 | DOI:10.1080/17474124.2024.2319580 (Source: Expert Review of Gastroenterology and Hepatology)
Source: Expert Review of Gastroenterology and Hepatology - February 14, 2024 Category: Gastroenterology Authors: Peter Konyn Brandon J Perumpail Karn Wijarnpreecha George Cholankeril Aijaz Ahmed Donghee Kim Source Type: research
Correction
Expert Rev Gastroenterol Hepatol. 2024 Feb 5:1. doi: 10.1080/17474124.2024.2314810. Online ahead of print.NO ABSTRACTPMID:38317353 | DOI:10.1080/17474124.2024.2314810 (Source: Expert Review of Gastroenterology and Hepatology)
Source: Expert Review of Gastroenterology and Hepatology - February 6, 2024 Category: Gastroenterology Source Type: research
Comparative effectiveness of warfarin in cirrhotic patients with non-symptomatic portal vein thrombosis: a multicenter, randomized controlled trial
In conclusion, warfarin was proved to be an effective and safe as an anticoagulation therapy for treating non-symptomatic PVT in cirrhotic patients.PMID:38236640 | DOI:10.1080/17474124.2024.2307575 (Source: Expert Review of Gastroenterology and Hepatology)
Source: Expert Review of Gastroenterology and Hepatology - January 18, 2024 Category: Gastroenterology Authors: Shenxin Lu Jie Chen Rui Zhang Tiancheng Luo Lili Ma Pengju Xu Hong Ding Xiaoqing Zeng Bing Wu Yihai Shi Chenghai Liu Yongping Mu Shiyao Chen Jian Wang Source Type: research
Influence of metabolic dysfunction-associated fatty liver disease on the prognosis of patients with HBV-related acute-on-chronic liver failure
CONCLUSION: The presence of MAFLD in patients with HBV-related ACLF was associated with an increased risk of in-hospital mortality. Moreover, The TIM2 model is a high-performance prognostic score for HBV-related ACLF.PMID:38164659 | DOI:10.1080/17474124.2023.2298261 (Source: Expert Review of Gastroenterology and Hepatology)
Source: Expert Review of Gastroenterology and Hepatology - January 2, 2024 Category: Gastroenterology Authors: Rui-Min Lai Li-Xi Yao Shan Lin Jia-Hui Zhou Bing-Ping Liu Zhao-Yi Liang Tianbin Chen Jia-Ji Jiang Qi Zheng Yueyong Zhu Source Type: research
Influence of metabolic dysfunction-associated fatty liver disease on the prognosis of patients with HBV-related acute-on-chronic liver failure
CONCLUSION: The presence of MAFLD in patients with HBV-related ACLF was associated with an increased risk of in-hospital mortality. Moreover, The TIM2 model is a high-performance prognostic score for HBV-related ACLF.PMID:38164659 | DOI:10.1080/17474124.2023.2298261 (Source: Expert Review of Gastroenterology and Hepatology)
Source: Expert Review of Gastroenterology and Hepatology - January 2, 2024 Category: Gastroenterology Authors: Rui-Min Lai Li-Xi Yao Shan Lin Jia-Hui Zhou Bing-Ping Liu Zhao-Yi Liang Tianbin Chen Jia-Ji Jiang Qi Zheng Yueyong Zhu Source Type: research
Influence of metabolic dysfunction-associated fatty liver disease on the prognosis of patients with HBV-related acute-on-chronic liver failure
CONCLUSION: The presence of MAFLD in patients with HBV-related ACLF was associated with an increased risk of in-hospital mortality. Moreover, The TIM2 model is a high-performance prognostic score for HBV-related ACLF.PMID:38164659 | DOI:10.1080/17474124.2023.2298261 (Source: Expert Review of Gastroenterology and Hepatology)
Source: Expert Review of Gastroenterology and Hepatology - January 2, 2024 Category: Gastroenterology Authors: Rui-Min Lai Li-Xi Yao Shan Lin Jia-Hui Zhou Bing-Ping Liu Zhao-Yi Liang Tianbin Chen Jia-Ji Jiang Qi Zheng Yueyong Zhu Source Type: research
